Skye Bioscience, Inc. — Form D

Skye Bioscience, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-15. The offering totals $32.5M, of which $2.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Avtar L DhillonDirectorLong Beach, CA
Punit S DhillonDirectorSan Diego, CA
James L HeppellDirectorSan Diego, CA
Brian S MurphyDirectorLong Beach, CA
Douglas A CesarioExecutive OfficerLong Beach, CA
Brian S MurphyExecutive OfficerLong Beach, CA
Andrew SchwabDirectorBOSTON, MA
Praveen TyleDirectorEncinitas, CA
Annalisa JenkinsDirectorDallas, TX
Margaret DalesandroDirectorSan Diego, CA
Punit DhillonDirectorSan Diego, CA
Punit DhillonExecutive OfficerSan Diego, CA
Kaitlyn ArsenaultExecutive OfficerSan Diego, CA
Deborah CharychDirectorSan Diego, CA
Paul GraysonDirectorSan Diego, CA
Keith WardDirectorSan Diego, CA
Douglas S IngramDirectorCAMBRIDGE, MA
Douglas S IngramExecutive OfficerCAMBRIDGE, MA
Elizabeth M BereczExecutive OfficerCosta Mesa, CA
Jim S HeppellDirectorCosta Mesa, CA
Gerald W McLaughlinDirectorCosta Mesa, CA
Cosmas N LykosDirectorCosta Mesa, CA
Cosmas N LykosExecutive OfficerCosta Mesa, CA
Thomas A GeorgeDirectorCosta Mesa, CA
John B HollisterDirectorScottsdale, AZ

Other filings by this issuer (16)

Showing 15 of 16 filings.

FiledFormOfferingSold
2024-03-27D$40.0M$40.0M
2024-02-12D$50.0M$50.0M
2023-08-29D$62.3M$62.3M
2018-02-23D/A$8.6M$4.2M
2018-01-25D$6.8M$2.4M
2017-11-14D$2.0M$2.0M
2017-01-13D$1.5M$1.2M
2016-11-03D$500K$500K
2015-08-27D$5.0M$5.0M
2015-04-15D$2.5M$625K
2015-01-09D$725K$725K
2014-11-13D
2013-01-22D/A$25K$25K
2012-11-08D
2012-11-07D/A$9K$9K

More